470 related articles for article (PubMed ID: 23069758)
1. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
Gao A; Peng Y; Deng Y; Qing H
Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
[TBL] [Abstract][Full Text] [Related]
2. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
3. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
Ito D; Okano H; Suzuki N
Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
[TBL] [Abstract][Full Text] [Related]
4. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.
Jung YW; Hysolli E; Kim KY; Tanaka Y; Park IH
Curr Opin Neurol; 2012 Apr; 25(2):125-30. PubMed ID: 22357218
[TBL] [Abstract][Full Text] [Related]
5. Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.
Zhao P; Luo Z; Tian W; Yang J; Ibáñez DP; Huang Z; Tortorella MD; Esteban MA; Fan W
Exp Biol Med (Maywood); 2014 Nov; 239(11):1421-32. PubMed ID: 24939824
[TBL] [Abstract][Full Text] [Related]
6. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
8. Generation and genetic modification of induced pluripotent stem cells.
Schambach A; Cantz T; Baum C; Cathomen T
Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
[TBL] [Abstract][Full Text] [Related]
9. Human stem cell research and regenerative medicine--present and future.
Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
[TBL] [Abstract][Full Text] [Related]
10. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
Ito D; Yagi T; Suzuki N
Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
[TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
Yoshida Y; Yamanaka S
Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
13. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
Csöbönyeiová M; Polák Š; Danišovič L
Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
15. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
Pen AE; Jensen UB
Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
López-González R; Velasco I
Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
[TBL] [Abstract][Full Text] [Related]
17. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
[TBL] [Abstract][Full Text] [Related]
18. Stemming the hype: what can we learn from iPSC models of Parkinson's disease and how can we learn it?
Jacobs BM
J Parkinsons Dis; 2014; 4(1):15-27. PubMed ID: 24398656
[TBL] [Abstract][Full Text] [Related]
19. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
[TBL] [Abstract][Full Text] [Related]
20. Stem cell challenges in the treatment of neurodegenerative disease.
Feng Z; Gao F
CNS Neurosci Ther; 2012 Feb; 18(2):142-8. PubMed ID: 22070610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]